Oscar Health stock (NYSE: OSCR) has recently increased to over $16 after reports of a possible two-year extension of Obamacare subsidies, which may positively influence demand for health insurance via ...

Lululemon's growth story isn't as smooth as it once was, but the stock now trades at a valuation that seemed impossible just a few years ago. Today, that narrative looks very different. After several ...

I upgraded MU to a Strong Buy after its 180% YTD rally, as its forward non-GAAP P/E fell to 14x, down from 16x in my last rating. The cheaper valuation is driven by significant upward revisions to ...